The IDM has curated a go-to range of reliable information to guide and assist staff and students during this time of crisis. We are continuously updating the various COVID-19 resources listed on our webpage below.
The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.
University accredited research institute - Tackling diseases of importance in Africa - Developing people - Impacting health policy and practice
The HIV/Aids pandemic taught us about equitable access to treatment and the need for transparency, accountability and protecting the most vulnerable. The University of Cape Town’s (UCT) Professor Linda-Gail Bekker stands as a reminder that this applies in a time of COVID-19 too.
Cape Bio Pharms, a biotech company with roots in the University of Cape Town’s (UCT) Biopharming Research Unit, has received a multimillion-rand capital injection to fast-track the production of affordable plant-based rapid diagnostic COVID-19 test kits.
Three University of Cape Town (UCT) researchers have been included in the Highly Cited Researchers (HCR) list for 2020. They are HCR veterans Emeritus Professor William Bond and Professor Dan Stein, as well as Professor Estelle (Vicki) Lambert who features on the list for the first time this year.
Last month the Institute of Infectious Disease and Molecular Medicine (IDM) hosted the annual IDM Postgraduate Student Publication Competition – an initiative of the Institute Transformation Committee.